Qrativ Company

Qrativ is a developer of a drug purposing platform designed to reinvent the way treatments for diseases with unmet medical.
Technology: Cancer
Industry: Drug Repurposing
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2017
Employees Number: 11-50
Funding Status: Early Stage Venture
Estimated Revenue: $1M to $10M

Visit Website
agustin@nference.net
Register and Claim Ownership